• 1
    Deraco M, Baratti D, Inglese MG, et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol. 2004; 11: 393398.
  • 2
    Deraco M, Casali P, Inglese MG, et al. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol. 2003; 83: 147153.
  • 3
    Ryu KS, Kim JH, Ko HS, et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol. 2004; 94: 325332.
  • 4
    Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004; 22: 32843292.
  • 5
    Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003; 21: 37373743.
  • 6
    Raspagliesi F, Deraco M, Rossi CR. Stage III/IV epithelial ovarian cancer with macroscopic residual disease after 1st line chemotherapy: a multicentric prospective randomized study comparing locoregional approach + systemic chemotherapy vs. systemic chemotherapy alone. Available from URL: [Accessed August 1, 2005].
  • 7
    Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995; 221: 2942.
  • 8
    Sugarbaker PH. Laser-mode electrosurgery. Cancer Treat Res. 1996; 82: 375385.
  • 9
    Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996; 15: 4958.
  • 10
    Fujimoto S, Takahashi M, Kobayashi K, et al. Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case. Surg Today. 1993; 23: 10941098.
  • 11
    Rossi CR, Foletto M, Mocellin S, et al. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer. 2002; 94: 492499.
  • 12
    Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet. 2001; 358: 14871492.
  • 13
    Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting the results of cancer treatment. Cancer. 1981; 47: 207214.
  • 14
    Gonzalez Bayon L, Sugarbaker PH, Gonzalez Moreno S, Vazquez Vde L, Alves S, Moran BJ. Initiation of a program in peritoneal surface malignancy. Surg Oncol Clin N Am. 2003; 12: 741753.
  • 15
    Abete M, Ronchetti V, Casano A, Pescio G. [ Anastomotic leakage after traditional surgery of the colon and rectum]. Minerva Chir. 2003; 58: 167174. Review. Italian.
  • 16
    Montesani C, De Milito R, Chiappalone S, Narilli P, D'Amato A, Ribotta G. Critical evaluation of the anastomoses in large bowel surgery: experience gained in 533 cases. Hepatogastroenterology. 1992; 39: 304308.
  • 17
    Fumagalli U, Trabucchi E, Soligo M, et al. Effects of intraperitoneal chemotherapy on anastomotic healing in rats. J Surg Res. 1991; 50: 8287.
  • 18
    Makrin V, Lev-Chelouche D, Even Sapir E, Paran H, Rabau M, Gutman M. Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study. J Surg Oncol. 2005; 89: 1822.
  • 19
    Kuzu M, Koksoy C, Kale T, Demirpence E, Renda N. Experimental study of the effect of preoperative 5-fluorouracil on the integrity of colonic anastomoses. Br J Surg. 1998; 85: 236239.
  • 20
    Arikan AY, Gunal O, Pehlivan M, Alper M. The effect of intraperitoneal paclitaxel administration on colonic anastomosis. Hepatogastroenterology. 2000; 47: 12731276.
  • 21
    Shimizu T, Maeta M, Koga. Influence of local hyperthermia on the healing of small intestinal anastomoses in the rat. Br J Surg. 1991; 78: 5759.
  • 22
    Elias D, Laurent S, Antoun S, et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy. Gastroenterol Clin Biol. 2003; 27: 407412.
  • 23
    Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001; 92: 7176.
  • 24
    Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996; 77: 26222629.
  • 25
    Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg. 2004; 91: 747754.
  • 26
    Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol. 2004; 85: 6167.
  • 27
    Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003; 12: 585603.
  • 28
    Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg, 1997; 30: 233280.
  • 29
    Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol. 2004; 11: 178186.
  • 30
    Younan R, Kusamura S, Baratti D, et al. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2005; 12: 910918.
  • 31
    Loggie BW, Fleming R. Complications of heated intraperitoneal chemotherapy and strategies for prevention. In: SugarbakerPH, editor. Peritoneal carcinomatosis: principles of management. Boston: Kluwer Academic, 1996: 222223.
  • 32
    Chen MY, Chiles C, Loggie BW, Choplin RH, Perini MA, Fleming RA. Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery. J Surg Oncol. 1997; 66: 1923.
  • 33
    Ahmad SA, Kim J, Sussman JJ, et al. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol. 2004; 11: 387392.
  • 34
    Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999; 6: 790796.
  • 35
    Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003; 10: 863869.
  • 36
    Cavaliere F, Di Filippo F, Cosimelli M, et al. The integrated treatment of peritoneal carcinomatosis. A preliminary experience. J Exp Clin Cancer Res. 1999; 18: 151158.
  • 37
    Sugarbaker PH, Jacquet P, Stephens AD, Stuart OA, Averbach AM. Comparison of covered versus closed technique for heated intraoperative chemotherapy for peritoneal carcinomatosis from gastrointestinal cancer. In: AbeO, InokuchiK, TakasakiK, editors. XXX World Congress of the International College of Surgeons. Bologna, Italy: Monduzzi Editore, 1996; 389393.
  • 38
    Leunig M, Goetz AE, Dellian M, et al. Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. Cancer Res. 1992; 52: 487490.
  • 39
    Milosevic MF, Fyles AW, Hill RP. The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis. Int J Radiat Oncol Biol Phys. 1999; 43: 11111123.
  • 40
    Jain RK, Baxter LT. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 1988; 48(24 Pt 1): 70227032.
  • 41
    Jacquet P, Stuart OA, Chang D, Sugarbaker PH. Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs. 1996; 7: 596603.
  • 42
    Deraco M, Vaglini M, Santinami M, Santoro N, Inglese MG, Spatti GB. Intraperitoneal hyperthermic perfusion (IPHP): analysis of morbidity and toxicity. Oncol Rep. 1996; 3: 11031106.
  • 43
    Deraco M, Rossi CR, Pennacchioli E, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori. 2001; 87: 120126.
  • 44
    Zanon C, Clara R, Bortolini M, et al. Chemohyperthermia for advanced abdominal malignancies: a new procedure with closed abdomen and previously performed anastomosis. Int J Hyperthermia. 2001; 17: 456464.